Novel Lentivirus-Based Method for Rapid Selection of Inhibitory Nanobody against PRRSV

Viruses. 2020 Feb 19;12(2):229. doi: 10.3390/v12020229.

Abstract

The emergence and re-emergence of porcine reproductive and respiratory syndrome virus (PRRSV) has resulted in huge economic losses for the swine industry. Current vaccines are of limited efficacy against endemic circulating PRRSV variants. New strategies against PRRSV infection are in urgent need. Here, a nanobody library in Marc-145 cells is constructed for antiviral nanobodies. Nanobody encoding sequences from two non-immunized llamas were cloned to generate a pseudotyped lentiviral library. Several candidates were selected from survival cells post-PRRSV inoculation and further characterized. Nb9 was identified with strong antiviral activity. Moreover, Nb9 exerted antiviral activity via its interaction with PRRSV viral proteins, as revealed by immunofluorescence assay and Western blot. Taken together, the novel function-based screen of the lentivirus nanobody library, instead of the conventional affinity-based screen, offers an alternative strategy for antiviral reagents against PRRSV and other pathogens.

Keywords: PRRSV; antiviral strategy; lentivirus based nanobody library; nanobody selection.

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology*
  • Camelids, New World
  • Cell Line
  • Lentivirus / genetics*
  • Peptide Library
  • Porcine respiratory and reproductive syndrome virus / drug effects*
  • Single-Domain Antibodies / genetics
  • Single-Domain Antibodies / pharmacology*
  • Swine
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • Peptide Library
  • Single-Domain Antibodies